Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2026)
Adaptive Biotechnologies (ADPT) posted Return on Capital Employed of 11.06% for Q1 2026, up 20.25% sequentially from 13.87% in Q4 2025, and up 2173.0% YoY from 0.49% in Q1 2025.
Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Return on Capital Employed for 8 years, with the latest figure at 11.06% in Q1 2026.
- Quarterly Return on Capital Employed rose 2173.0% year-over-year to 11.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.06% (up 2173.0% YoY) and the FY2025 annual result came in at 13.1%, up 1927.0% from the prior year.
- Return on Capital Employed rose to 11.06% in Q1 2026 per ADPT's latest filing, from 13.87% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 11.06% in Q1 2026 and troughed at 42.39% in Q2 2024.
- A 5-year average of 29.75% and a median of 30.02% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed tumbled 1462 bps in 2024, then soared 2221 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 26.32% in 2022, then sank by 43 bps to 37.75% in 2023, then increased by 5 bps to 36.05% in 2024, then soared by 62 bps to 13.87% in 2025, then climbed by 20 bps to 11.06% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.06%, 13.87%, and 19.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 6.42% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -13.91% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 10.49% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 68.60% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 49.80% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.97% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | -7.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.71% |
| Mar 31, 2026 | -11.06% |
| Dec 31, 2025 | -13.87% |
| Sep 30, 2025 | -19.06% |
| Jun 30, 2025 | -29.42% |
| Mar 31, 2025 | -32.79% |
| Dec 31, 2024 | -36.05% |
| Sep 30, 2024 | -41.27% |
| Jun 30, 2024 | -42.39% |
| Mar 31, 2024 | -39.19% |
| Dec 31, 2023 | -37.75% |
| Sep 30, 2023 | -30.12% |
| Jun 30, 2023 | -27.78% |
| Mar 31, 2023 | -26.48% |
| Dec 31, 2022 | -26.32% |
| Sep 30, 2022 | -30.02% |
| Jun 30, 2022 | -32.39% |
| Mar 31, 2022 | -29.75% |
| Dec 31, 2021 | -24.75% |
| Sep 30, 2021 | -21.51% |